• Home
  • Aktivitäten
  • Über Uns
  • Destinations
  • Kontakt
DVFK
  • Home
  • Aktivitäten
  • Über Uns
  • Destinations
  • Kontakt
DVFK-ATIVITÄTEN

6. VIETNAMESE GERMAN SCIENTIFIC SYMPOSIUM NHA TRANG 2016

11/29/2016

0 Kommentare

 
Bild
6. VIETNAMESE GERMAN SCIENTIFIC SYMPOSIUM NHA TRANG
29.11.2016
Venue: General Hospital Khanh Hoa
​Times: 14:00 -17:00

Organization:
General Hospital Khanh Hoa
 
in Cooperation with
  • Khanh Hoa Heart Association
  • German Vietnamese Association of Cardiology/ Deutsch-Vietnamesischer Förderkreis für Kardiologie e.V. (DVFK)
  • Vietnamese German Academy for Science and Education in Cardiology and
    Cardiovascular Surgery (VGAC)
  • Vietnamese German Faculty of Medicine of Pham Ngoc Thach University of Medicine at Ho Chi Minh City (VGFM)

Lectures:
 
Atrial Fibrillation - Update 2016: New Guidelines, Ablative Treatment, Drugs, Studies
Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Cologne, Germany 

Ventricular Tachycardia - Update 2016: Guidelines, Ablative Treatment, Drugs, Studies
Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Cologne, Germany 

Antitcoagulation and Antithrombotic Therapy in Patients with Atrial Fibrillation (AF)  and Acute Coronary Syndrome – Update 2016
Prof. Dr. Hans-F. Voehringer, Clinical Research Centre, DRK Kliniken I Koepenick, Germany
 
Transradial vs. transfemoral access in patients with ACS: Bleeding complications and Outcome
Dr. Ralph Schoeller (on behalf of Berlin Myocardial Infarction Registry), Clinic for Cardiology of DRK Kliniken Berlin I Westend, Germany
 
Cardiac Rehabilitation – Update 2016
Günter Haug, M.D., FESC , Rehabilitation Center, German Pension Insurance Federation,
Bayerisch Gmain, Germany
 

Non-invasive positive pressure ventilation for the treatment of chronic obstructive pulmonary disease (COPD) - Update 2016
Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC,  HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the Otto-von-Guericke University Magdeburg, Germany
 
FACULTY:
 
Dr. Günter Haug, FESC , Rehabilitation Center, German Pension Insurance Federation, Bayerisch Gmain, Germany
Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany 
Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC,  HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the Otto-von-Guericke University Magdeburg, Germany
Dr. Ralph Schoeller, Clinic for Cardiology of DRK Kliniken Berlin I Westend, Germany
Prof. Dr. Hans-F. Voehringer, Clinical Research Centre, DRK Kliniken I Koepenick, Germany

Bild
0 Kommentare

16. VIETNAMESE GERMAN HEART DAYS  HCMC 2016

11/27/2016

0 Kommentare

 
16. VIETNAMESE GERMAN HEART DAYS 2016
SCIENTIFIC SYMPOSIUM HCMC
27.11.2016

Organization:
Vietnamese Heart Association of Ho Chi Minh City
 
in Cooperation with
  • German Vietnamese Association of Cardiology/ Deutsch-Vietnamesischer Förderkreis für Kardiologie e.V. (DVFK)
  • Vietnamese German Academy for Science and Education in Cardiology and Cardiovascular Surgery (VGAC)
  • Vietnamese German Faculty of Medicine of Pham Ngoc Thach University of Medicine at Ho Chi Minh City (VGFM)

Lectures:
 
Atrial Fibrillation - Update 2016: New Guidelines, Ablative Treatment, Drugs, Studies
Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Cologne, Germany 

​Summary:
  • Drugs useful in case of heart rate control strategy
  • In persistent atrial fibrillation, actual studies shows benefit of ablative treatment compared to medical therapy
  • First line AF Ablation is established
  • Early treatment of atrial fibrillation  beneficial
 
Ventricular Tachycardia - Update 2016: Guidelines, Ablative Treatment, Drugs, Studies
Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Cologne, Germany 

Summary:
  • VT with consecutive ICD interventions worsen prognosis
  • Early VT Ablation indicated
  • Electrical storm: multi-modal therapy concept
  • Epicardial Ablation useful
 
Antitcoagulation and Antithrombotic Therapy in Patients with Atrial Fibrillation (AF)  and Acute Coronary Syndrome – Update 2016
Prof. Dr. Hans-F. Voehringer, Clinical Research Centre, DRK Kliniken I Koepenick, Germany
 
Background: Guidelines for treatment of atrial fibrillation (AF) and coronary revascularisation recommend individual treatment regimen for patients with AF and acute coronary syndrome (ACS) according to their risk of bleeding or suffering from thrombo-embolic complications. The aim of the present  study is to illustrate how guidelines are implemented into daily practice and whether treatment approaches have changed over time since the introduction of new oral anticoagulants (NOACs).
 
Methods and Results: From January 2011 to December 2014 we included 1537 AF patients with ACS into a registry (Berlin Myocardial Infarction Registry) collecting data on hospital treatment, hospital mortality, and discharge medication.
790 out of these patients received DES (51.4%), 277 BMS (18%), 125 only balloon dilatation (8.1%) and 345 no intervention (22.4%), respectively. 95 % of patients had a CHA2DS2-VASc Score >1, the hospital mortality amounted to 9.8%.
 
Table 1: Anticoagulation for AF patients with ACS discharged from hospital
               with CHA2DS2-VASc Score >1  
 
Table 2: Discharge medication for  patients treated with stents dismissed
               from hospital with CHA2DS2-VASc Score >1

Conclusion:  In Tab 1 and 2 the percentage of patients treated with anticoagulation is seen over a time period of 4 years. While the percentage of patients treated with heparin and Vitamin-K antagonists has remained the same, those patients treated with NOACs have increased. Nearly 60% of AF patients with ACS received a triple therapy. The findings will be discussed in light of published data in the literature. Newer and specifically designed trials are awaited for further improvement of the existing knowledge about efficacy and safety of this combination therapy.
 
Transradial vs. transfemoral access in patients with ACS: Bleeding complications and Outcome
Dr. Ralph Schoeller (on behalf of Berlin Myocardial Infarction Registry), Clinic for Cardiology of DRK Kliniken Berlin I Westend, Germany
 
Background: The use of transradial access for PCI is growing and the newly published guidelines on treatment of ACS take account of this, provided the necessary experience exists. We studied ways of access in treatment of ACS patients under real world conditions in a big city.
Methods:  Our Registry collects data on hospital treatment of patients with ACS since 1999. Since 1.4.2011 data on different ways of PCI access are collected. In our study we included all 10,146 patients treated with PCI from 20 hospitals between 1.4.11-31.12.14. We studied bleeding complications according to GUSTO criteria (mild, moderate, severe) and we analysed the influence of transfemoral vs. transradial access on hospital mortality.
Results: 4165 patients were treated with transradial (41,1%), 5981 with transfemoral (58,9%) PCI access. Transfemoral vs. transradial access influences hospital mortality (OR=1.53; 95% CI: 1.18–1.98) and also influences chances of moderate to severe bleeding (OR=1.69; 95% CI: 1.17–2.45) even after adjustment for differences in patient characteristics and in antiplatelet and antithrombotic therapy. 

Table: Differences between patients with transradial vs. transfemoral access

Conclusion:
  1. Transradial access is being used in 41.1% of cases for treatment of ACS patients.
  2. Mild, moderate and severe bleeding occurred significantly less often after transradial compared to transfemoral access.
  3. Chances of moderate to severe bleeding are increased with transfemoral access even after adjustment for differences between patients.
  4. Hospital mortality is higher for patients with transfemoral access even after adjustment for differences in patients' mix.
 
Cardiac Rehabilitation – Update 2016
Günter Haug, M.D., FESC , Rehabilitation Center, German Pension Insurance Federation, Bayerisch Gmain, Germany 

The aim of this lecture is to give an update 2016 of cardiac rehabilitation (rehab) according to international guidelines (AHA, AAVPR, EAPR of ESC) focussed on strategies how to organize modern cardiac rehab.
Class I indications for post-surgical and post-interventional referral and logistic feasibilities to transfer these eligible patients to in-patient resident or out-patient cardiac rehab units will be presented. Evidence based benefits and safety as well as concerns and risks of early and continued cardiac rehab are described. Based on our experience out of a 230-bed cardiac rehabilitation center overlooking more than 3000 in-patient rehab cases a year we discuss requirements for structures, core competencies of staff and core components of cardiac rehab in the different phases of recovery. Guideline based programs covering the 5 core components of cardiac rehab, in particular supervised exercise training, patient education on specific heart condition of cardiovascular diseases (CVD) as well as strategies to improve risk factors and to stop smoking, to achieve medication adherence and emotional recovery will be presented. We therefore demonstrate in particular rehab specific medical admission, rehabilitation care, risk stratification, prescription of supervised exercise training, courses to improve risk factors considering country specific needs as well as to achieve medication adherence. The objectives of early and continued cardiac rehab are to overcome postoperative and post-interventional physical and functional handicaps, to avoid early complications, further cardiac events and progression of CVD, to cope with psychosocial problems, and to reintegrate in job and family. 
In summery core components of modern cardiac rehabilitation will be presented based on our specific experience and according to latest study results and current guidelines. Roadmaps how to organize cardiac rehab in order to improve early and long-term outcome and last but not least in order to discharge acute hospital wards, to raise the number of operations and interventions, and therefore to increase the number of treatable patients esp. in low-resource settings will be discussed.
 
Non-invasive positive pressure ventilation for the treatment of chronic obstructive pulmonary disease (COPD) - Update 2016
Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC,  HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the Otto-von-Guericke University Magdeburg, Germany
 
The non-invasive ventilation (NIV) has been established for about 20 years as a successful treatment method for acute respiratory insufficiency (ARI), as home ventilation it has been used in the last 10 years by hypercapnic COPD patients increasingly.
A persistent hypercapnia for medically treated patients with COPD is a manifest sign of the failure of the respiratory pump and thus indicates a poor prognosis of the disease. It is also regarded as a criterion for initiating nocturnal home ventilation with a non-invasive, pressure-controlled ventilation (NPPV). This measure is primarily to improve the quality of life. In a recently published study by Köhnlein et al a relevant life extension by NPPV has now been documented in patients with a chronic failure of the respiratory pump in COPD for the first time.
The pathophysiology of COPD, indications and contraindications for NIV in ARI and nocturnal home ventilation, techniques and practical application of non-invasive ventilation are presented.
 
FACULTY:
 
Dr. Günter Haug, FESC , Rehabilitation Center, German Pension Insurance Federation,
Bayerisch Gmain, Germany

Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany 
Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC,  HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the Otto-von-Guericke University Magdeburg, Germany
Dr. Ralph Schoeller, Clinic for Cardiology of DRK Kliniken Berlin I Westend, Germany
Prof. Dr. Hans-F. Voehringer, Clinical Research Centre, DRK Kliniken I Koepenick, Germany
0 Kommentare

    Archiv

    November 2019
    September 2019
    August 2018
    Dezember 2017
    November 2017
    September 2017
    Dezember 2016
    November 2016
    September 2016
    Dezember 2015
    November 2015
    September 2015
    November 2014
    September 2014
    November 2013
    September 2013
    November 2012
    September 2012
    Dezember 2011
    November 2011
    November 2010
    September 2010
    November 2009
    September 2009
    November 2008
    September 2008
    September 2007
    März 2007
    November 2006
    Oktober 2006
    September 2006
    November 2005
    September 2005
    Juni 2005
    November 2004
    September 2004
    Februar 2004
    November 2003
    September 2003
    Dezember 2002
    November 2002
    September 2002
    November 2001
    September 2001
    Juni 2001
    November 1998
    Oktober 1998
    März 1998
    April 1997
    Juni 1996
    April 1994
    April 1991
    Oktober 1988
    Juni 1988
    Januar 1988
    März 1986
    April 1985

    RSS-Feed

Powered by Create your own unique website with customizable templates.
  • Home
  • Aktivitäten
  • Über Uns
  • Destinations
  • Kontakt